Arsanis, Inc. was incorporated in 2010 and is based in Lebanon, New Hampshire. Arsanis also operates as Arsanis Biosciences in Vienna, Austria, and according to a job posting, the company is focused on developing infectious disease treatments based on similar bacterial protein and carbohydrate antigens as GlycoFi.
Current Team (10)Update
Co - Founder & Board Member
Director, Antibody and Antigen Production and Analytics Department
Co - Founder& Chairman
Director of Vienna Operations
Senior Vice President, Product Development
Director, Immunology & In Vitro Assays and Translational Medicine Departments
President, Founfer & CSO
Director, Microbiology & In Vivo Models Department
Funding Rounds (3) - $30.4MUpdate
Board Members and Advisors (4)Update
International venture capital investment
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
Venture capital Firm
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
Campus Vienna Biocenter 4
Dr. Bohr-Gasse 3